 | • レポートコード：D005-00440 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん治療におけるゲノミクスの世界市場を広く調査・分析し、今後の市場展望をまとめております。がん治療におけるゲノミクスの種類別市場規模（器具、消耗品、サービス）、用途別市場規模（診断、個別化医療、創薬、開発、研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Illumina、Danaher、Roche、Thermo Fisher scientific、Bio-Rad、Agilent、Pacific Biosciences、Beckman Coulter、Cancer Genetics、Sigma Aldrich、Qiagen、Quest Diagnostics、GE Healthcare、PerkinElmer、Luminex、Thermo Fisher scientific、Oxford Gene Technology ・地域別グローバル市場分析 2015年-2020年 ・がん治療におけるゲノミクスの北米市場（アメリカ、カナダ、メキシコ） ・がん治療におけるゲノミクスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん治療におけるゲノミクスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん治療におけるゲノミクスの南米市場（ブラジル、アルゼンチン） ・がん治療におけるゲノミクスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：器具、消耗品、サービス ・用途別分析：診断、個別化医療、創薬、開発、研究 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Genomics In Cancer Care market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.4% in the forecast period of 2020 to 2025 and will expected to reach USD 22870 million by 2025, from USD 15970 million in 2019.
The Genomics In Cancer Care market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Genomics In Cancer Care market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Genomics In Cancer Care market has been segmented into:
Instruments
Consumables
Services
By Application, Genomics In Cancer Care has been segmented into:
Diagnostics
Personalized Medicine
Drug Discovery
Development
Research
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Genomics In Cancer Care market presented in the report. This section sheds light on the sales growth of different regional and country-level Genomics In Cancer Care markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genomics In Cancer Care market.
The report offers in-depth assessment of the growth and other aspects of the Genomics In Cancer Care market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Genomics In Cancer Care Market Share Analysis
Genomics In Cancer Care competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genomics In Cancer Care sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genomics In Cancer Care sales, revenue and market share for each player covered in this report.
The major players covered in Genomics In Cancer Care are:
Illumina
Danaher
Roche
Thermo Fisher scientific
Bio-Rad
Agilent
Pacific Biosciences
Beckman Coulter
Cancer Genetics
Sigma Aldrich
Qiagen
Quest Diagnostics
GE Healthcare
PerkinElmer
Luminex
Thermo Fisher scientific
Oxford Gene Technology
Table of Contents
1 Genomics In Cancer Care Market Overview
1.1 Product Overview and Scope of Genomics In Cancer Care
1.2 Classification of Genomics In Cancer Care by Type
1.2.1 Global Genomics In Cancer Care Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Genomics In Cancer Care Revenue Market Share by Type in 2019
1.2.3 Instruments
1.2.4 Consumables
1.2.5 Services
1.3 Global Genomics In Cancer Care Market by Application
1.3.1 Overview: Global Genomics In Cancer Care Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Global Genomics In Cancer Care Market by Regions
1.4.1 Global Genomics In Cancer Care Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Genomics In Cancer Care (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomics In Cancer Care Status and Prospect (2015-2025)
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Illumina SWOT Analysis
2.1.4 Illumina Product and Services
2.1.5 Illumina Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Danaher SWOT Analysis
2.2.4 Danaher Product and Services
2.2.5 Danaher Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher scientific
2.4.1 Thermo Fisher scientific Details
2.4.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher scientific SWOT Analysis
2.4.4 Thermo Fisher scientific Product and Services
2.4.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bio-Rad SWOT Analysis
2.5.4 Bio-Rad Product and Services
2.5.5 Bio-Rad Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent
2.6.1 Agilent Details
2.6.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent SWOT Analysis
2.6.4 Agilent Product and Services
2.6.5 Agilent Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pacific Biosciences
2.7.1 Pacific Biosciences Details
2.7.2 Pacific Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pacific Biosciences SWOT Analysis
2.7.4 Pacific Biosciences Product and Services
2.7.5 Pacific Biosciences Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beckman Coulter
2.8.1 Beckman Coulter Details
2.8.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beckman Coulter SWOT Analysis
2.8.4 Beckman Coulter Product and Services
2.8.5 Beckman Coulter Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cancer Genetics
2.9.1 Cancer Genetics Details
2.9.2 Cancer Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cancer Genetics SWOT Analysis
2.9.4 Cancer Genetics Product and Services
2.9.5 Cancer Genetics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sigma Aldrich
2.10.1 Sigma Aldrich Details
2.10.2 Sigma Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sigma Aldrich SWOT Analysis
2.10.4 Sigma Aldrich Product and Services
2.10.5 Sigma Aldrich Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Qiagen SWOT Analysis
2.11.4 Qiagen Product and Services
2.11.5 Qiagen Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.12 Quest Diagnostics
2.12.1 Quest Diagnostics Details
2.12.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Quest Diagnostics SWOT Analysis
2.12.4 Quest Diagnostics Product and Services
2.12.5 Quest Diagnostics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.13 GE Healthcare
2.13.1 GE Healthcare Details
2.13.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GE Healthcare SWOT Analysis
2.13.4 GE Healthcare Product and Services
2.13.5 GE Healthcare Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.14 PerkinElmer
2.14.1 PerkinElmer Details
2.14.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 PerkinElmer SWOT Analysis
2.14.4 PerkinElmer Product and Services
2.14.5 PerkinElmer Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.15 Luminex
2.15.1 Luminex Details
2.15.2 Luminex Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Luminex SWOT Analysis
2.15.4 Luminex Product and Services
2.15.5 Luminex Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.16 Thermo Fisher scientific
2.16.1 Thermo Fisher scientific Details
2.16.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Thermo Fisher scientific SWOT Analysis
2.16.4 Thermo Fisher scientific Product and Services
2.16.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.17 Oxford Gene Technology
2.17.1 Oxford Gene Technology Details
2.17.2 Oxford Gene Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Oxford Gene Technology SWOT Analysis
2.17.4 Oxford Gene Technology Product and Services
2.17.5 Oxford Gene Technology Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Genomics In Cancer Care Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Genomics In Cancer Care Players Market Share
3.2.2 Top 10 Genomics In Cancer Care Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Genomics In Cancer Care Revenue and Market Share by Regions
4.2 North America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.3 Europe Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.5 South America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
5 North America Genomics In Cancer Care Revenue by Countries
5.1 North America Genomics In Cancer Care Revenue by Countries (2015-2020)
5.2 USA Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
5.3 Canada Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
5.4 Mexico Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6 Europe Genomics In Cancer Care Revenue by Countries
6.1 Europe Genomics In Cancer Care Revenue by Countries (2015-2020)
6.2 Germany Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.3 UK Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.4 France Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.5 Russia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.6 Italy Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Genomics In Cancer Care Revenue by Countries
7.1 Asia-Pacific Genomics In Cancer Care Revenue by Countries (2015-2020)
7.2 China Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.3 Japan Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.4 Korea Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.5 India Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
8 South America Genomics In Cancer Care Revenue by Countries
8.1 South America Genomics In Cancer Care Revenue by Countries (2015-2020)
8.2 Brazil Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
8.3 Argentina Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Genomics In Cancer Care by Countries
9.1 Middle East & Africa Genomics In Cancer Care Revenue by Countries (2015-2020)
9.2 Saudi Arabia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9.3 UAE Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9.4 Egypt Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9.5 South Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Genomics In Cancer Care Revenue and Market Share by Type (2015-2020)
10.2 Global Genomics In Cancer Care Market Forecast by Type (2019-2024)
10.3 Instruments Revenue Growth Rate (2015-2025)
10.4 Consumables Revenue Growth Rate (2015-2025)
10.5 Services Revenue Growth Rate (2015-2025)
11 Global Genomics In Cancer Care Market Segment by Application
11.1 Global Genomics In Cancer Care Revenue Market Share by Application (2015-2020)
11.2 Genomics In Cancer Care Market Forecast by Application (2019-2024)
11.3 Diagnostics Revenue Growth (2015-2020)
11.4 Personalized Medicine Revenue Growth (2015-2020)
11.5 Drug Discovery Revenue Growth (2015-2020)
11.6 Development Revenue Growth (2015-2020)
11.7 Research Revenue Growth (2015-2020)
12 Global Genomics In Cancer Care Market Size Forecast (2021-2025)
12.1 Global Genomics In Cancer Care Market Size Forecast (2021-2025)
12.2 Global Genomics In Cancer Care Market Forecast by Regions (2021-2025)
12.3 North America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.4 Europe Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.6 South America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Genomics In Cancer Care Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Genomics In Cancer Care Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Genomics In Cancer Care by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Genomics In Cancer Care Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Genomics In Cancer Care Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Illumina Corporate Information, Location and Competitors
Table 6. Illumina Genomics In Cancer Care Major Business
Table 7. Illumina Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 8. Illumina SWOT Analysis
Table 9. Illumina Genomics In Cancer Care Product and Solutions
Table 10. Illumina Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Danaher Corporate Information, Location and Competitors
Table 12. Danaher Genomics In Cancer Care Major Business
Table 13. Danaher Genomics In Cancer Care Total Revenue (USD Million) (2018-2019)
Table 14. Danaher SWOT Analysis
Table 15. Danaher Genomics In Cancer Care Product and Solutions
Table 16. Danaher Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche Genomics In Cancer Care Major Business
Table 19. Roche Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche Genomics In Cancer Care Product and Solutions
Table 22. Roche Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher scientific Genomics In Cancer Care Major Business
Table 25. Thermo Fisher scientific Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher scientific SWOT Analysis
Table 27. Thermo Fisher scientific Genomics In Cancer Care Product and Solutions
Table 28. Thermo Fisher scientific Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bio-Rad Corporate Information, Location and Competitors
Table 30. Bio-Rad Genomics In Cancer Care Major Business
Table 31. Bio-Rad Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 32. Bio-Rad SWOT Analysis
Table 33. Bio-Rad Genomics In Cancer Care Product and Solutions
Table 34. Bio-Rad Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Agilent Corporate Information, Location and Competitors
Table 36. Agilent Genomics In Cancer Care Major Business
Table 37. Agilent Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 38. Agilent SWOT Analysis
Table 39. Agilent Genomics In Cancer Care Product and Solutions
Table 40. Agilent Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pacific Biosciences Corporate Information, Location and Competitors
Table 42. Pacific Biosciences Genomics In Cancer Care Major Business
Table 43. Pacific Biosciences Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 44. Pacific Biosciences SWOT Analysis
Table 45. Pacific Biosciences Genomics In Cancer Care Product and Solutions
Table 46. Pacific Biosciences Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beckman Coulter Corporate Information, Location and Competitors
Table 48. Beckman Coulter Genomics In Cancer Care Major Business
Table 49. Beckman Coulter Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 50. Beckman Coulter SWOT Analysis
Table 51. Beckman Coulter Genomics In Cancer Care Product and Solutions
Table 52. Beckman Coulter Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Cancer Genetics Corporate Information, Location and Competitors
Table 54. Cancer Genetics Genomics In Cancer Care Major Business
Table 55. Cancer Genetics Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 56. Cancer Genetics SWOT Analysis
Table 57. Cancer Genetics Genomics In Cancer Care Product and Solutions
Table 58. Cancer Genetics Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sigma Aldrich Corporate Information, Location and Competitors
Table 60. Sigma Aldrich Genomics In Cancer Care Major Business
Table 61. Sigma Aldrich Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 62. Sigma Aldrich SWOT Analysis
Table 63. Sigma Aldrich Genomics In Cancer Care Product and Solutions
Table 64. Sigma Aldrich Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Qiagen Corporate Information, Location and Competitors
Table 66. Qiagen Genomics In Cancer Care Major Business
Table 67. Qiagen Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 68. Qiagen SWOT Analysis
Table 69. Qiagen Genomics In Cancer Care Product and Solutions
Table 70. Qiagen Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Quest Diagnostics Corporate Information, Location and Competitors
Table 72. Quest Diagnostics Genomics In Cancer Care Major Business
Table 73. Quest Diagnostics Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 74. Quest Diagnostics SWOT Analysis
Table 75. Quest Diagnostics Genomics In Cancer Care Product and Solutions
Table 76. Quest Diagnostics Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. GE Healthcare Corporate Information, Location and Competitors
Table 78. GE Healthcare Genomics In Cancer Care Major Business
Table 79. GE Healthcare Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 80. GE Healthcare SWOT Analysis
Table 81. GE Healthcare Genomics In Cancer Care Product and Solutions
Table 82. GE Healthcare Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. PerkinElmer Corporate Information, Location and Competitors
Table 84. PerkinElmer Genomics In Cancer Care Major Business
Table 85. PerkinElmer Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 86. PerkinElmer SWOT Analysis
Table 87. PerkinElmer Genomics In Cancer Care Product and Solutions
Table 88. PerkinElmer Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Luminex Corporate Information, Location and Competitors
Table 90. Luminex Genomics In Cancer Care Major Business
Table 91. Luminex Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 92. Luminex SWOT Analysis
Table 93. Luminex Genomics In Cancer Care Product and Solutions
Table 94. Luminex Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Thermo Fisher scientific Corporate Information, Location and Competitors
Table 96. Thermo Fisher scientific Genomics In Cancer Care Major Business
Table 97. Thermo Fisher scientific Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 98. Thermo Fisher scientific SWOT Analysis
Table 99. Thermo Fisher scientific Genomics In Cancer Care Product and Solutions
Table 100. Thermo Fisher scientific Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Oxford Gene Technology Corporate Information, Location and Competitors
Table 102. Oxford Gene Technology Genomics In Cancer Care Major Business
Table 103. Oxford Gene Technology Genomics In Cancer Care Total Revenue (USD Million) (2017-2018)
Table 104. Oxford Gene Technology SWOT Analysis
Table 105. Oxford Gene Technology Genomics In Cancer Care Product and Solutions
Table 106. Oxford Gene Technology Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Genomics In Cancer Care Revenue (Million USD) by Players (2015-2020)
Table 108. Global Genomics In Cancer Care Revenue Share by Players (2015-2020)
Table 109. Global Genomics In Cancer Care Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Genomics In Cancer Care Revenue Market Share by Regions (2015-2020)
Table 111. North America Genomics In Cancer Care Revenue by Countries (2015-2020)
Table 112. North America Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Table 113. Europe Genomics In Cancer Care Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Genomics In Cancer Care Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Genomics In Cancer Care Revenue by Countries (2015-2020)
Table 116. South America Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Genomics In Cancer Care Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Table 119. Global Genomics In Cancer Care Revenue (Million USD) by Type (2015-2020)
Table 120. Global Genomics In Cancer Care Revenue Share by Type (2015-2020)
Table 121. Global Genomics In Cancer Care Revenue Forecast by Type (2021-2025)
Table 122. Global Genomics In Cancer Care Revenue by Application (2015-2020)
Table 123. Global Genomics In Cancer Care Revenue Share by Application (2015-2020)
Table 124. Global Genomics In Cancer Care Revenue Forecast by Application (2021-2025)
Table 125. Global Genomics In Cancer Care Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Genomics In Cancer Care Picture
Figure 2. Global Genomics In Cancer Care Revenue Market Share by Type in 2019
Figure 3. Instruments Picture
Figure 4. Consumables Picture
Figure 5. Services Picture
Figure 6. Genomics In Cancer Care Revenue Market Share by Application in 2019
Figure 7. Diagnostics Picture
Figure 8. Personalized Medicine Picture
Figure 9. Drug Discovery Picture
Figure 10. Development Picture
Figure 11. Research Picture
Figure 12. Global Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Genomics In Cancer Care Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Genomics In Cancer Care Revenue Market Share in 2019
Figure 21. Global Top 10 Players Genomics In Cancer Care Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Genomics In Cancer Care Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Genomics In Cancer Care Revenue Market Share by Regions (2015-2020)
Figure 25. Global Genomics In Cancer Care Revenue Market Share by Regions in 2018
Figure 26. North America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 27. Europe Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 29. South America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 31. North America Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Figure 32. North America Genomics In Cancer Care Revenue Market Share by Countries in 2019
Figure 33. USA Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 34. Canada Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 36. Europe Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Genomics In Cancer Care Revenue Market Share by Countries in 2019
Figure 38. Germany Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 39. UK Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 40. France Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 41. Russia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 42. Italy Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Genomics In Cancer Care Revenue Market Share by Countries in 2019
Figure 45. China Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 46. Japan Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 47. Korea Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 48. India Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 50. South America Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Figure 51. South America Genomics In Cancer Care Revenue Market Share by Countries in 2019
Figure 52. Brazil Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 57. UAE Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
Figure 60. Global Genomics In Cancer Care Revenue Share by Type (2015-2020)
Figure 61. Global Genomics In Cancer Care Revenue Share by Type in 2019
Figure 62. Global Genomics In Cancer Care Market Share Forecast by Type (2021-2025)
Figure 63. Global Instruments Revenue Growth Rate (2015-2020)
Figure 64. Global Consumables Revenue Growth Rate (2015-2020)
Figure 65. Global Services Revenue Growth Rate (2015-2020)
Figure 66. Global Genomics In Cancer Care Revenue Share by Application (2015-2020)
Figure 67. Global Genomics In Cancer Care Revenue Share by Application in 2019
Figure 68. Global Genomics In Cancer Care Market Share Forecast by Application (2021-2025)
Figure 69. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 70. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 71. Global Drug Discovery Revenue Growth Rate (2015-2020)
Figure 72. Global Development Revenue Growth Rate (2015-2020)
Figure 73. Global Research Revenue Growth Rate (2015-2020)
Figure 74. Global Genomics In Cancer Care Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Genomics In Cancer Care Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Genomics In Cancer Care Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
Figure 78. Europe Genomics In Cancer Care Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Genomics In Cancer Care Revenue Market Forecast (2021-2025)
Figure 80. South America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Genomics In Cancer Care Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
がん検査/スクリーニングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Testing/Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Testing/Scree…- 大腸がん診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 肛門がん及び結腸直腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anal and Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anal and Colorecta…
- がん支持療法医学の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Supportive Care Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Suppor…
- がん腫瘍プロファイリングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Tumor Profiling market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 54970 million by 2025, from USD 37570 million in 2019. The Cancer Tumor P…